SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation

Archive ouverte

Delmonte, Ottavia | Bergerson, Jenna | Kawai, Tomoki | Kuehn, Hye Sun | Mcdermott, David | Cortese, Irene | Zimmermann, Michael | Dobbs, A. Kerry | Bosticardo, Marita | Fink, Danielle | Majumdar, Shamik | Palterer, Boaz | Pala, Francesca | Dsouza, Nikita | Pouzolles, Marie | Daley, Stephen | Taylor, Naomi | Calvo, Katherine | Velez, Daniel | Agharahimi, Anahita | Myint-Hpu, Katherine | Dropulic, Lesia | Lyons, Jonathan | Holland, Steven | Freeman, Alexandra | Ghosh, Rajarshi | Similuk, Morgan | Niemela, Julie | Stoddard, Jennifer | Kuhns, Douglas | Urrutia, Raul | Rosenzweig, Sergio | Walkiewicz, Magdalena | Murphy, Philip | Notarangelo, Luigi

Edité par CCSD ; American Society of Hematology -

International audience. Sterile alpha motif (SAM) and Src homology-3 (SH3) domain-containing 3 (SASH3), also called SH3-containing lymphocyte protein (SLY1), is a putative adaptor protein that is postulated to play an important role in the organization of signaling complexes and propagation of signal transduction cascades in lymphocytes. The SASH3 gene is located on the X-chromosome. Here, we identified 3 novel SASH3 deleterious variants in 4 unrelated male patients with a history of combined immunodeficiency and immune dysregulation that manifested as recurrent sinopulmonary, cutaneous, and mucosal infections and refractory autoimmune cytopenias. Patients exhibited CD4+ T-cell lymphopenia, decreased T-cell proliferation, cell cycle progression, and increased T-cell apoptosis in response to mitogens. In vitro T-cell differentiation of CD34+ cells and molecular signatures of rearrangements at the T-cell receptor α (TRA) locus were indicative of impaired thymocyte survival. These patients also manifested neutropenia and B-cell and natural killer (NK)-cell lymphopenia. Lentivirus-mediated transfer of the SASH3 complementary DNA–corrected protein expression, in vitro proliferation, and signaling in SASH3-deficient Jurkat and patient-derived T cells. These findings define a new type of X-linked combined immunodeficiency in humans that recapitulates many of the abnormalities reported in mice with Sly1–/– and Sly1Δ/Δ mutations, highlighting an important role of SASH3 in human lymphocyte function and survival.

Consulter en ligne

Suggestions

Du même auteur

The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1

Archive ouverte | Oikonomou, Vasileios | CCSD

International audience. Background: Autoimmune polyendocrine syndrome type 1 (APS-1) is a life-threatening, autosomal recessive syndrome caused by autoimmune regulator (AIRE) deficiency. In APS-1, self-reactive T ce...

Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency

Archive ouverte | Boutboul, David | CCSD

International audience. Ikaros/IKZF1 is an essential transcription factor expressed throughout hematopoiesis. IKZF1 is implicated in lymphocyte and myeloid differentiation and negative regulation of cell proliferati...

Genetically corrected RAG2 -SCID human hematopoietic stem cells restore V(D)J-recombinase and rescue lymphoid deficiency

Archive ouverte | Pavel-Dinu, Mara | CCSD

International audience. Abstract Recombination-activating genes (RAG1 and RAG2) are critical for lymphoid cell development and function by initiating the variable (V), diversity (D), and joining (J) (V(D)J)-recombin...

Chargement des enrichissements...